Why is AbbVie Inc. stock up today?
October 17, 2026
AbbVie Inc.
ABBV · NYQ · USD
vs. prev. close $283.4
Last updated Oct 16, 2026 20:00
Intraday Chart — 5-min intervals
ABBV · less than a minute ago
AbbVie Inc.: a price move with limited explanatory evidence
At $285.42, ABBV has changed +0.71% versus its previous close of $283.40.
The data confirms the price change, not its cause. No fresh, identifiable event in this feed supports a confident explanation.
S&P 500 is -1.09% versus +0.71% for ABBV. The stock is outperforming by 1.81 percentage points. The divergence argues against a simple market-only explanation; it does not identify a company catalyst.
Reliable volume comparisons are unavailable, so participation cannot be used to strengthen this explanation.
Key Factors
Auto-generated analysis · Not financial advice
AbbVie’s Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
24/7 Wall St.·about 11 hours agoneutral
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Motley Fool·about 14 hours agoneutral
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
PR Newswire·about 17 hours agoneutral
What AbbVie (ABBV)'s Phase 3 Lymphoma Win Means For Shareholders
Simply Wall St.·about 17 hours agoneutral
What Was Eli Lilly Telling You Before Its Stock Ran?
Trefis·about 20 hours agoneutral
When Amgen's Forecast And Chart Say The Same Thing, Pay Attention
Trefis·about 22 hours agoneutral
Gilead’s HIV Prevention Business Just Topped $1 Billion A Quarter. What Comes Next?
Trefis·about 22 hours agoneutral
Is Amgen Stock Increasing Your Market Risk?
Trefis·about 22 hours agoneutral
S&P 500
-1.09%
Nasdaq
-2.14%
Dow Jones
-0.34%
Shanghai
+0.24%
Hang Seng
+0.52%
Nikkei 225
+1.39%
FTSE 100
+0.38%
Nifty 50
+0.65%
DAX
+0.95%
OMX Stockholm
+1.25%
Advertisement
Search another stock